Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Irritable Bowel Syndrome, March 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 112 articles: HTML format

Single Articles

1. VAN BARNEVELD E, Lim A, van Hanegem N, van Osch F, et al
   Real-time Symptom Assessment in Patients With Endometriosis: Psychometric Evaluation of an Electronic Patient-Reported Outcome Measure, Based on the Experience Sampling Method.
   JMIR Form Res. 2023;7:e29480.
   PubMed    
   Abstract available
   
   

2. LACY BE, Cangemi DJ, Spiegel BR
   Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain Interaction?
   Gastroenterol Hepatol (N Y). 2023;19:86-94.
   PubMed    
   Abstract available
   
   

3. BOUSTANY A, Onwuzo S, Almomani A, Asaad I, et al
   Epidemiology and risk of colorectal cancer in patients with a history of Helicobacter pylori infection: a population-based study.
   Ann Gastroenterol. 2023;36:203-207.
   PubMed    
   Abstract available
   
   

4. LIANG H, Li L, Huang L, Lu T, et al
   HLA-A and HLA-B genes are involved in the pathogenesis of IBS.
   Medicine (Baltimore). 2023;102:e33135.
   PubMed    
   Abstract available
   
   

5. ZHOU J, Zhou B, Kou X, Jian T, et al
   Effect of summer acupoint application treatment (SAAT) on gut microbiota in healthy Asian adults: A randomized controlled trial.
   Medicine (Baltimore). 2023;102:e32951.
   PubMed    
   Abstract available
   
   

6. HIGASHIYAMA M, Miura S, Hokari R
   Modulation by luminal factors on the functions and migration of intestinal innate immunity.
   Front Immunol. 2023;14:1113467.
   PubMed    
   Abstract available
   
   

7. FERREIRA GS, Dijkstra FM, Veening-Griffioen DH, Boon WPC, et al
   Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs.
   Transl Psychiatry. 2023;13:74.
   PubMed    
   Abstract available
   
   

8. WANG ZW, Chen BW, Chen SZ, Zhang LL, et al
   [Effect of electroacupuncture at "Zusanli" (ST36) and "Tianshu" (ST25) on intestinal function and autonomic nerve balance in rats with irritable bowel syndrome].
   Zhen Ci Yan Jiu. 2023;48:165-71.
   PubMed    
   Abstract available
   
   

9. GOODOORY VC, Tuteja AK, Black CJ, Ford AC, et al
   Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.
   Clin Gastroenterol Hepatol. 2023 Feb 27:S1542-3565(23)00156.
   PubMed    
   Abstract available
   
   

10. BLACK CJ, Ng CE, Goodoory VC, Ford AC, et al
    Novel Symptom Subgroups in Individuals with Irritable Bowel Syndrome Predict Disease Impact and Burden.
    Clin Gastroenterol Hepatol. 2023 Feb 27:S1542-3565(23)00158.
    PubMed    
    Abstract available
    
    

11. FIORINI G, Saracino IM, Pavoni M, Nipote B, et al
    Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR(R)) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2023;69:123-127.
    PubMed    
    Abstract available
    
    

12. ZHANG P, Ma Y, Wang Z, Tang D, et al
    The effect and mechanism of Sancao Lichang Decoction on Diarrhea-predominant Irritable Bowel Syndrome by regulating TLR4/MyD88/NF-kappaB pathway.
    Comb Chem High Throughput Screen. 2023.
    PubMed    
    Abstract available
    
    

13. TAO L, Du F
    Letter to the editor: Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
    Clin Nutr. 2023 Feb 17:S0261-5614(23)00038-9. doi: 10.1016/j.clnu.2023.
    PubMed    
    
    
    

14. KERN D, Ljotsson B, Lonndahl L, Hedman-Lagerlof E, et al
    Brief self-guided digital intervention versus a comprehensive therapist-guided online cognitive behavioural therapy for atopic dermatitis: a trial protocol for a randomised non-inferiority trial.
    BMJ Open. 2023;13:e068908.
    PubMed    
    Abstract available
    
    

15. PANARELLI NC, Hornick JL, Yantiss RK
    What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?
    Mod Pathol. 2023;36:100005.
    PubMed    
    Abstract available
    
    

16. GHOLAMNEZHAD F, Qeisari A, Shahriarirad R
    Gastroesophageal reflux disease incidence among male patients with irritable bowel syndrome: A single-center cross-sectional study in southern Iran.
    JGH Open. 2023;7:152-156.
    PubMed    
    Abstract available
    
    

17. BECKER N, Maisner A
    Nipah Virus Impairs Autocrine IFN Signaling by Sequestering STAT1 and STAT2 into Inclusion Bodies.
    Viruses. 2023;15:554.
    PubMed    
    Abstract available
    
    

18. REDIJ R, Kaur A, Muddaloor P, Sethi AK, et al
    Practicing Digital Gastroenterology through Phonoenterography Leveraging Artificial Intelligence: Future Perspectives Using Microwave Systems.
    Sensors (Basel). 2023;23:2302.
    PubMed    
    Abstract available
    
    

19. SHIVJI S, Conner JR, Kirsch R
    Mast Cell Evaluation in Gastrointestinal Biopsies: Should We Be Counting? A Critical Review and Practical Guide for the Surgical Pathologist.
    Histopathology. 2023 Feb 27. doi: 10.1111/his.14897.
    PubMed    
    Abstract available
    
    

20. HASAN SS, Ballou S, Keefer L, Vasant DH, et al
    Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a "smart" solution?
    Neurogastroenterol Motil. 2023 Feb 27:e14554. doi: 10.1111/nmo.14554.
    PubMed    
    Abstract available
    
    

21. HEYDARI P, Ghanadian M, Asghari G, Azimi M, et al
    A double-blind randomized clinical trial of Dracocephalum kotschyi Boiss. in the patients with diarrhea-predominant irritable bowel syndrome.
    Res Pharm Sci. 2022;18:89-99.
    PubMed    
    Abstract available
    
    

22. ONWUZO S, Boustany A, Khaled Abou Zeid H, Hitawala A, et al
    Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study.
    Cureus. 2023;15:e34088.
    PubMed    
    Abstract available
    
    

23. CAMINERO A, Guzman M, Libertucci J, Lomax AE, et al
    The emerging roles of bacterial proteases in intestinal diseases.
    Gut Microbes. 2023;15:2181922.
    PubMed    
    Abstract available
    
    

24. VAN MALDEREN K, De Man JG, De Winter BY, De Schepper HU, et al
    Epidemiological characteristics of a population visiting a patient-centered informative website about irritable bowel syndrome.
    Acta Gastroenterol Belg. 2023;86:17-25.
    PubMed    
    Abstract available
    
    

25. VANUYTSEL T, Reenaers C
    Essential reading from the editor's desk.
    Acta Gastroenterol Belg. 2023;86:3-4.
    PubMed    
    
    
    

26. HASEGAWA R, Saito-Nakaya K, Gu L, Kanazawa M, et al
    Maternal separation and TNBS-induced gut inflammation synergistically alter the sexually differentiated stress response in rats.
    Biopsychosoc Med. 2023;17:7.
    PubMed    
    Abstract available
    
    

27. LIU X, Wang Q, Chen M, Tao J, et al
    Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes.
    J Ethnopharmacol. 2023;308:116303.
    PubMed    
    Abstract available
    
    

28. CASTRO J, Maddern J, Chow CY, Tran P, et al
    The voltage-gated sodium channel Na(V) 1.7 underlies endometriosis-associated chronic pelvic pain.
    J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15795.
    PubMed    
    Abstract available
    
    

29. SAHA S, Patel N
    What Should I Eat? Dietary Recommendations for Patients with Inflammatory Bowel Disease.
    Nutrients. 2023;15:896.
    PubMed    
    Abstract available
    
    

30. TZIATZIOS G, Gkolfakis P, Leite G, Mathur R, et al
    Probiotics in Functional Dyspepsia.
    Microorganisms. 2023;11:351.
    PubMed    
    Abstract available
    
    

31. MARCHIX J, Queneherve L, Bordron P, Aubert P, et al
    Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study.
    Microorganisms. 2023;11:277.
    PubMed    
    Abstract available
    
    

32. JAMES SC, Fraser K, Cooney J, Gunther CS, et al
    Concentrations of Plasma Amino Acids and Neurotransmitters in Participants with Functional Gut Disorders and Healthy Controls.
    Metabolites. 2023;13:313.
    PubMed    
    Abstract available
    
    

33. SUN W, Qing R, Fan Z, He Q, et al
    Mechanism of Wuyao-Ginseng Medicine Pair in the Prevention and Treatment of Diarrhea-Type Irritable Bowel Syndrome Based on Gene Expression Omnibus Chip Data.
    Life (Basel). 2023;13:339.
    PubMed    
    Abstract available
    
    

34. FRITSCHE LG, Jin W, Admon AJ, Mukherjee B, et al
    Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US.
    J Clin Med. 2023;12:1328.
    PubMed    
    Abstract available
    
    

35. GALGANO F, Mele MC, Tolve R, Condelli N, et al
    Strategies for Producing Low FODMAPs Foodstuffs: Challenges and Perspectives.
    Foods. 2023;12:856.
    PubMed    
    Abstract available
    
    

36. MILUSHEVA M, Gledacheva V, Stefanova I, Pencheva M, et al
    In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors.
    Biomedicines. 2023;11:605.
    PubMed    
    Abstract available
    
    

37. RAT LA, Moldovan AF, Trifan DF, Matis L, et al
    Can the Correlation of Periodontopathies with Gastrointestinal Diseases Be Used as Indicators in Severe Colorectal Diseases?
    Biomedicines. 2023;11:402.
    PubMed    
    Abstract available
    
    

38. BRADSHAW E
    Diverticular disease, diverticulitis and the impact on continence.
    Br J Nurs. 2023;32:168-172.
    PubMed    
    Abstract available
    
    

39. SCHOLL CL, Davies PL
    Protein engineering of antifreeze proteins reveals that their activity scales with the area of the ice-binding site.
    FEBS Lett. 2023;597:538-546.
    PubMed    
    Abstract available
    
    

40. AGOSTINI A, Benuzzi F, Ballotta D, Rizzello F, et al
    Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages.
    Inflamm Bowel Dis. 2023 Mar 10:izad029. doi: 10.1093.
    PubMed    
    Abstract available
    
    

41. ZARINI GG, McLean MA, Delgado SI
    Is Personalized Dietary Therapy Effective for Individuals With Irritable Bowel Syndrome?
    Am J Lifestyle Med. 2022;17:317-325.
    PubMed    
    Abstract available
    
    

42. SONG J, Chen W, Ye W
    Stroke and the risk of gastrointestinal disorders: A Mendelian randomization study.
    Front Neurol. 2023;14:1131250.
    PubMed    
    Abstract available
    
    

43. MURPHY CC, Cirillo PM, Krigbaum NY, Singal AG, et al
    In utero exposure to anti-emetic and risk of adult-onset colorectal cancer.
    JNCI Cancer Spectr. 2023 Mar 10:pkad021. doi: 10.1093.
    PubMed    
    Abstract available
    
    

44. LOUWIES T, Mohammadi E, Greenwood-Van Meerveld B
    Epigenetic mechanisms underlying stress-induced visceral pain: Resilience versus vulnerability in a two-hit model of early life stress and chronic adult stress.
    Neurogastroenterol Motil. 2023 Mar 9:e14558. doi: 10.1111/nmo.14558.
    PubMed    
    Abstract available
    
    

45. PATEJDL R, Demir IE, Frieling T, Goebel-Stengel M, et al
    Curricular representation of neurogastroenterology: A survey among medical students in Germany.
    Neurogastroenterol Motil. 2023 Mar 9:e14557. doi: 10.1111/nmo.14557.
    PubMed    
    Abstract available
    
    

46. MACONI G, Dell'Era A, Flor N, De Silvestri A, et al
    ULTRASONOGRAPHIC AND FUNCTIONAL FEATURES OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE.
    Clin Transl Gastroenterol. 2023 Mar 9. doi: 10.14309/ctg.0000000000000580.
    PubMed    
    Abstract available
    
    

47. VERSPYCK E, Attal N
    Diagnosing nociplastic pain in cancer survivors: a major step forward.
    Br J Anaesth. 2023 Mar 6:S0007-0912(23)00064-8. doi: 10.1016/j.bja.2023.
    PubMed    
    Abstract available
    
    

48. SAULINO DM, Chandran A, Ambelil M, Al Salihi S, et al
    Colonic Eosinophilia: Clinicopathologic Study of Paired Right and Left Colon Biopsies from 276 Patients.
    Ann Clin Lab Sci. 2023;53:76-81.
    PubMed    
    Abstract available
    
    

49. KUMEI S, Ishioh M, Nozu T, Okumura T, et al
    Prostaglandin I(2) suppresses the development of gut-brain axis disorder in irritable bowel syndrome in rats.
    Biochim Biophys Acta Gen Subj. 2023;1867:130344.
    PubMed    
    Abstract available
    
    

50. KORNER E, Lorentz A
    Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    J Appl Microbiol. 2023 Mar 7:lxad044. doi: 10.1093.
    PubMed    
    Abstract available
    
    

51. WU S, Yang Z, Yuan C, Liu S, et al
    Coffee and tea intake with long-term risk of irritable bowel syndrome: a large-scale prospective cohort study.
    Int J Epidemiol. 2023 Mar 7:dyad024. doi: 10.1093.
    PubMed    
    Abstract available
    
    

52. ESPANA-CUETO S, Oliveira-Souto I, Salvador F, Goterris L, et al
    Post-infectious irritable bowel syndrome following a diagnosis of traveller's diarrhoea: a comprehensive characterization of clinical and laboratory parameters.
    J Travel Med. 2023 Mar 6:taad030. doi: 10.1093.
    PubMed    
    Abstract available
    
    

53. YUAN L, Xiao H, Li H, Yan B, et al
    APETx2 regulates intestinal motility and visceral sensitivity in post-infectious irritable bowel syndrome mice through 5-HT signalling pathway.
    J Pharm Pharmacol. 2023 Mar 4:rgad017. doi: 10.1093.
    PubMed    
    Abstract available
    
    

54. NAMAKIN K, Moghaddam MH, Sadeghzadeh S, Mehranpour M, et al
    Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome.
    Metab Brain Dis. 2023 Mar 6. doi: 10.1007/s11011-023-01187.
    PubMed    
    Abstract available
    
    

55. DIMITROVA-YURUKOVA D, Boyanov N, Nakov V, Nakov R, et al
    Diagnosis and management of irritable bowel syndrome-like symptoms in ulcerative colitis.
    Folia Med (Plovdiv). 2022;64:733-739.
    PubMed    
    Abstract available
    
    

56. WANG XP, Wang B
    Editorial: Highlights in abdominal and pelvic pain 2021/2022.
    Front Pain Res (Lausanne). 2023;4:1097072.
    PubMed    
    
    
    

57. XIAO J, Zhou YN, Yang YL, He L, et al
    Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis.
    Front Pharmacol. 2023;14:1044330.
    PubMed    
    Abstract available
    
    

58. ZU YQ, Li JH, Liao X, Yu Q, et al
    [Rapid health technology assessment of four oral Chinese patent medicines in treatment of functional gastrointestinal disorders].
    Zhongguo Zhong Yao Za Zhi. 2023;48:1116-1123.
    PubMed    
    Abstract available
    
    

59. ALGERA JP, Demir D, Tornblom H, Nybacka S, et al
    Reply - Letter to the editor: Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity.
    Clin Nutr. 2023 Feb 22:S0261-5614(23)00044-4. doi: 10.1016/j.clnu.2023.
    PubMed    
    
    
    

60. PANDIMEENA G, Mathavan T, James Jebaseelan Samuel E, Milton Franklin Benial A, et al
    Quantum chemical, spectroscopic and molecular docking studies on methyl 2-chloro-6-methyl pyridine-4-carboxylate: A potential inhibitor for irritable bowel syndrome.
    Spectrochim Acta A Mol Biomol Spectrosc. 2023;294:122544.
    PubMed    
    Abstract available
    
    

61. LU K, Gao Z, Wang X, Qiao X, et al
    The hyper-brain neural couplings distinguishing high-creative group dynamics: an fNIRS hyperscanning study.
    Cereb Cortex. 2023;33:1630-1642.
    PubMed    
    Abstract available
    
    

62. MAROTO C, Fiz-Lopez A, Pastor R, Bernardo D, et al
    Plasma levels of intestinal Fatty-Acid Binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol SIBO test.
    Rev Esp Enferm Dig. 2023 Mar 17. doi: 10.17235/reed.2023.9578/2023.
    PubMed    
    Abstract available
    
    

63. TOMINAGA K, Fujikawa Y
    Tryptase activates enteric glial cells followed by affecting neuronal properties possibly via the stimuli-associated mediators.
    J Pharmacol Sci. 2023;151:163-170.
    PubMed    
    Abstract available
    
    

64. CYPEL YS, Vogt D, Maguen S, Bernhard P, et al
    Physical health of Post-9/11 U.S. Military veterans in the context of Healthy People 2020 targeted topic areas: Results from the Comparative Health Assessment Interview Research Study.
    Prev Med Rep. 2023;32:102122.
    PubMed    
    Abstract available
    
    

65. LACY BE, Chang L, Rao SSC, Heimanson Z, et al
    Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Clin Ther. 2023 Mar 13:S0149-2918(23)00030.
    PubMed    
    Abstract available
    
    

66. MAJHI S, Kumar S, Singh L
    A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions.
    CNS Neurol Disord Drug Targets. 2023;22:659-677.
    PubMed    
    Abstract available
    
    

67. FU R, Liu S, Zhu M, Zhu J, et al
    Apigenin reduces the suppressive effect of exosomes derived from irritable bowel syndrome patients on the autophagy of human colon epithelial cells by promoting ATG14.
    World J Surg Oncol. 2023;21:95.
    PubMed    
    Abstract available
    
    

68. GERSON J, Tawde P, Ghiasian G, Salwen-Deremer JK, et al
    Patients' experiences with virtual group gut-directed hypnotherapy: A qualitative study.
    Front Med (Lausanne). 2023;10:1066452.
    PubMed    
    Abstract available
    
    

69. TANAKA Y, Ogino H, Ihara E
    [A stepwise treatment strategy based on the pathophysiology of irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2023;120:218-230.
    PubMed    
    
    
    

70. KANAZAWA M, Fukudo S
    [Diagnosis and pathophysiology of irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2023;120:209-217.
    PubMed    
    
    
    

71. OKUMURA T
    [Recent advances in irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2023;120:203-208.
    PubMed    
    
    
    

72. SUN Y, Liu X, Wang L, Li L, et al
    Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells.
    Eur J Pharmacol. 2023;946:175650.
    PubMed    
    Abstract available
    
    

73. CARON B, Ghosh S, Danese S, Peyrin-Biroulet L, et al
    Identifying, understanding and managing fecal urgency in inflammatory bowel diseases.
    Clin Gastroenterol Hepatol. 2023 Mar 9:S1542-3565(23)00172.
    PubMed    
    Abstract available
    
    

74. YANG L, Liu G, Li S, Yao C, et al
    Association of aberrant dynamic brain network and gut microbial composition uncovers the disrupted brain-gut-microbiome interactions in irritable bowel syndrome : preliminary findings.
    Eur J Neurol. 2023 Mar 11. doi: 10.1111/ene.15776.
    PubMed    
    Abstract available
    
    

75. CHOJNACKI C, Blonska A, Konrad P, Chojnacki M, et al
    Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome.
    Nutrients. 2023;15:1262.
    PubMed    
    Abstract available
    
    

76. SCHNEDL WJ, Michaelis S, Enko D, Mangge H, et al
    Fecal Calprotectin Elevations Associated with Food Intolerance/Malabsorption Are Significantly Reduced with Targeted Diets.
    Nutrients. 2023;15:1179.
    PubMed    
    Abstract available
    
    

77. HU C, Yan C, Wu Y, Tao E, et al
    Low FODMAP Diet Relieves Visceral Hypersensitivity and Is Associated with Changes in Colonic Microcirculation in Water Avoidance Mice Model.
    Nutrients. 2023;15:1155.
    PubMed    
    Abstract available
    
    

78. NARDONE OM, Marasco G, Lopetuso LR, Mocci G, et al
    Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.
    J Clin Med. 2023;12:2005.
    PubMed    
    Abstract available
    
    

79. WANG Z, Peng Y, Chen M, Peng L, et al
    The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
    J Clin Med. 2023;12:1865.
    PubMed    
    Abstract available
    
    

80. RODRIGUES T, Rodrigues Fialho S, Araujo JR, Rocha R, et al
    Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
    J Clin Med. 2023;12:1725.
    PubMed    
    Abstract available
    
    

81. WU L, Gao L, Jin X, Chen Z, et al
    Ethanol Extract of Mao Jian Green Tea Attenuates Gastrointestinal Symptoms in a Rat Model of Irritable Bowel Syndrome with Constipation via the 5-hydroxytryptamine Signaling Pathway.
    Foods. 2023;12:1101.
    PubMed    
    Abstract available
    
    

82. HREINSSON JP, Wong RKM, Tack J, Whorwell P, et al
    A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study.
    Neurogastroenterol Motil. 2023 Mar 24:e14566. doi: 10.1111/nmo.14566.
    PubMed    
    Abstract available
    
    

83. SWIERCZYNSKI M, Makaro A, Grochowska A, Salaga M, et al
    Pharmacological approaches to treat intestinal pain.
    Expert Rev Clin Pharmacol. 2023 Mar 24. doi: 10.1080/17512433.2023.2195626.
    PubMed    
    Abstract available
    
    

84. HOU YJ, Wang K, Jiang HL, Chen Y, et al
    [Study on the mechanism of electroacupuncture repairing intestinal barrier via regulating mast cell in rats with diarrhea-predominant irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2023;48:281-6.
    PubMed    
    Abstract available
    
    

85. ZOU L, Ruan JR, Chen JY, Wang JJ, et al
    [Moxibustion relieves colonic inflammation by up-regulating expression of miR-345-3p/miR-216a-5p and down-regulating NF-kappaB p65 in colonic tissue of rats with diarrhea-predominant irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2023;48:226-32.
    PubMed    
    Abstract available
    
    

86. BAYRER JR, Castro J, Venkataraman A, Touhara KK, et al
    Gut enterochromaffin cells drive visceral pain and anxiety.
    Nature. 2023 Mar 22. doi: 10.1038/s41586-023-05829.
    PubMed    
    Abstract available
    
    

87. JOHNSON JP, Diener C, Levine AE, Wilmanski T, et al
    Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with impaired kidney function.
    bioRxiv. 2023 Mar 6:2023.03.04.531100. doi: 10.1101/2023.03.04.531100.
    PubMed    
    Abstract available
    
    

88. CATASSI C, Catassi G, Naspi L
    Nonceliac gluten sensitivity.
    Curr Opin Clin Nutr Metab Care. 2023 Feb 16. doi: 10.1097/MCO.0000000000000925.
    PubMed    
    Abstract available
    
    

89. MALHOTRA D, Boyle SH, Gifford EJ, Sullivan BA, et al
    Self-reported gastrointestinal disorders among veterans with gulf war illness with and without posttraumatic stress disorder.
    Neurogastroenterol Motil. 2023 Mar 21:e14548. doi: 10.1111/nmo.14548.
    PubMed    
    Abstract available
    
    

90. ALZAHRANI MA, Alamri HA, Alshehri MA, Ayyashi MM, et al
    Assessing the relationship between burnout syndrome and irritable bowel syndrome among medical health providers and medical students in Saudi Arabia.
    J Med Life. 2023;16:277-283.
    PubMed    
    Abstract available
    
    

91. NORDIN E, Brunius C, Landberg R, Hellstrom PM, et al
    FODMAPs-Do they really affect IBS symptoms?
    Front Med (Lausanne). 2023;10:1123576.
    PubMed    
    
    
    

92. LIU M, Ye Z, Wu Q, Yang S, et al
    Healthy sleep, mental health, genetic susceptibility, and risk of irritable bowel syndrome.
    J Affect Disord. 2023;331:25-32.
    PubMed    
    Abstract available
    
    

93. SUN X, Yuan Y, Chen L, Ye M, et al
    Genetically predicted visceral adipose tissue and risk of nine non-tumour gastrointestinal diseases: evidence from a Mendelian randomization study.
    Int J Obes (Lond). 2023 Mar 18. doi: 10.1038/s41366-023-01279.
    PubMed    
    Abstract available
    
    

94. KALOLA UK, Chowdhury YS, Koretz RL
    JPEN Journal Club 76. Randomized crossover trials.
    JPEN J Parenter Enteral Nutr. 2023 Mar 4. doi: 10.1002/jpen.2496.
    PubMed    
    Abstract available
    
    

95. GUO L, Huang C, Lu J, Wu X, et al
    Decreased inter-brain synchronization in the right middle frontal cortex in alcohol use disorder during social interaction: An fNIRS hyperscanning study.
    J Affect Disord. 2023;329:573-580.
    PubMed    
    Abstract available
    
    

96. GUNN D, Topan R, Barnard L, Fried R, et al
    Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
    Aliment Pharmacol Ther. 2023 Mar 3. doi: 10.1111/apt.17426.
    PubMed    
    Abstract available
    
    

97. THWAITES PA, Burgell RE
    Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here?
    Aliment Pharmacol Ther. 2023;57:723-724.
    PubMed    
    
    
    

98. GOODOORY VC, Guthrie EA, Ng CE, Black CJ, et al
    Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' reply.
    Aliment Pharmacol Ther. 2023;57:725-726.
    PubMed    
    
    
    

99. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023 Mar 13. doi: 10.1111/apt.17465.
    PubMed    
    Abstract available
    
    

100. SHLOBIN AE, Tu FF, Sain CR, Kmiecik MJ, et al
     Bladder Pain Sensitivity Is a Potential Risk Factor for Irritable Bowel Syndrome.
     Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07868.
     PubMed    
     Abstract available
     
     

101. VICHOS T, Rezaie A, Vichos P, Cash B, et al
     Irritable Bowel Syndrome Is Not Associated with an Increased Risk of Polyps and Colorectal Cancer: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2023 Mar 4. doi: 10.1007/s10620-023-07885.
     PubMed    
     Abstract available
     
     

102. ZAMFIR-TARANU A, Loscher BS, Husein DM, Hoter A, et al
     Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients.
     Gut. 2023 Mar 6:gutjnl-2023-329695. doi: 10.1136/gutjnl-2023-329695.
     PubMed    
     
     
     

103. DAI C, Huang YH, Jiang M
     Post-COVID-19 irritable bowel syndrome.
     Gut. 2023 Mar 10:gutjnl-2023-329714. doi: 10.1136/gutjnl-2023-329714.
     PubMed    
     
     
     

104. GHOSHAL UC, Sachdeva S, Pratap N, Karyampudi A, et al
     Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian eurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology.
     Indian J Gastroenterol. 2023 Mar 24. doi: 10.1007/s12664-022-01333.
     PubMed    
     Abstract available
     
     

105. YAN L, Zhang X, Li Y, Liu C, et al
     The role of psychological factors in functional gastrointestinal disorders: a systematic review and meta-analysis.
     Int J Colorectal Dis. 2023;38:65.
     PubMed    
     Abstract available
     
     

106. LIU T, Ma M, Li K, Tan W, et al
     Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
     J Clin Gastroenterol. 2023 Mar 6. doi: 10.1097/MCG.0000000000001841.
     PubMed    
     Abstract available
     
     

107. YASUDA R, Arai K, Kudo T, Nambu R, et al
     Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan.
     J Gastroenterol Hepatol. 2023 Mar 6. doi: 10.1111/jgh.16166.
     PubMed    
     Abstract available
     
     

108. DENG X, Xiao L, Luo M, Xie P, et al
     Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome.
     J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16159.
     PubMed    
     Abstract available
     
     

109. OKUYAMA Y, Matsui D, Ozaki E, Watanabe Y, et al
     Association of low occlusal force as an oral hypofunction with the prevalence of irritable bowel syndrome in Japanese adults.
     J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16175.
     PubMed    
     Abstract available
     
     

110. KHOO XH, Chong CW, Talha AM, Philip K, et al
     The impact of diet and ethnicity on Gut Microbiota Variation in Irritable Bowel Syndrome: A Multi-centre Study.
     J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16174.
     PubMed    
     Abstract available
     
     

111. TOME J, Kamboj AK, Loftus CG
     Approach to Disorders of Gut-Brain Interaction.
     Mayo Clin Proc. 2023;98:458-467.
     PubMed    
     Abstract available
     
     

112. RAO STRB, Turek I, Irving HR
     Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa.
     PLoS One. 2023;18:e0281507.
     PubMed    
     Abstract available